高mtDNA含量识别了氧化酸化驱动的急性髓性白血病,并代表了治疗的脆弱性
Diego A Pereira-Martins1,2,3,4,5, Isabel Weinhäuser2,3,4,5, Emmanuel Griessinger2
1Department of Genetics, Federal University of Pernambuco, Recife, Brazil.
Signal transduction and targeted therapy
|July 13, 2025
概括
线粒体DNA含量 (mtDNAc) 可以识别抗化疗的急性髓性白血病 (AML) 患者. 针对线粒体新陈代谢的药物,如甲福明,结合NAMPT抑制剂,可以克服这种抵抗,改善AML的治疗策略.
科学领域:
- 癌症生物学 癌症生物学
- 代谢途径 代谢途径
- 线粒体功能的功能
背景情况:
- 代谢重编程是癌症的一个关键特征,包括急性髓性白血病 (AML).
- 线粒体功能对于癌细胞存活和AML中的化学抵抗至关重要.
- 了解代谢状态对于开发有效的AML疗法至关重要.
研究的目的:
- 为了确定一个可靠的标记物来分层AML患者的代谢状态.
- 研究线粒体新陈代谢与AML中的化学抵抗之间的联系.
- 探索针对AML中的代谢途径的新型治疗策略.
主要方法:
- 量化PCR用于测量AML患者的线粒体DNA含量 (mtDNAc).
- 用初级AML样本进行的ex vivo实验评估了化学阻力.
- 使用甲胺和其他向性药物进行药物敏感性测试.
主要成果:
- 高mtDNAc水平与线粒体代谢增加,OXPHOS依赖性和AML中的化学抵抗相关.
- 接受标准化疗 (7+3疗法) 的高mtDNAc患者表现较差.
- 抑制线粒体复合体I克服了细胞氨酸耐药性;甲胺增强了细胞亡,但通过糖解和NAD+生产诱导了耐药性,这种耐药性被NAMPT抑制所绕过.
结论:
- mtDNAc是评估AML细胞代谢状态和预测化学抵抗的精确标志物.
- 针对线粒体新陈代谢,可能使用甲胺和NAMPT抑制剂,为AML提供了一个有前途的个性化治疗策略.
- 临床实施mtDNAc测量可以为AML患者提供量身定制的治疗方法.
相关概念视频
01:20Mismatch Repair
5.2K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
5.2K
02:59Animal Mitochondrial Genetics
8.0K
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
8.0K
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
01:46Electron Transport Chain: Complex I and II
15.0K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
15.0K